BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 15256119)

  • 1. [Reversal of multidrug resistance of tumor cells by anti-mdr1 ribozyme].
    Gao P; Zhou GY; Zhang QH; Zhou CJ; Zhen JH; Sun YL
    Zhonghua Bing Li Xue Za Zhi; 2004 Jun; 33(3):251-4. PubMed ID: 15256119
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overcoming multi-drug resistance by anti-MDR1 ribozyme.
    Wang H; Chen XP; Qiu FZ
    World J Gastroenterol; 2003 Jul; 9(7):1444-9. PubMed ID: 12854138
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel approaches to reversing anti-cancer drug resistance using gene-specific therapeutics.
    Kobayashi H; Takemura Y; Miyachi H
    Hum Cell; 2001 Sep; 14(3):172-84. PubMed ID: 11774737
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reversal MDR in breast carcinoma cells by transfection of ribozyme designed according the secondary structure of mdr1 mRNA.
    Gao P; Zhou GY; Zhang QH; Li H; Mu K; Yuan YP; Zhang J; Wang BH
    Chin J Physiol; 2006 Apr; 49(2):96-103. PubMed ID: 16830791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Restoration of chemosensitivity in cancer cells with MDR phenotype by deoxyribozyme, compared with ribozyme.
    Xing AY; Shi DB; Liu W; Chen X; Sun YL; Wang X; Zhang JP; Gao P
    Exp Mol Pathol; 2013 Jun; 94(3):481-5. PubMed ID: 23531420
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reversal of drug resistance in breast carcinoma cells by anti-mdr1 ribozyme regulated by the tumor-specific MUC-1 promoter.
    Gao P; Zhou GY; Guo LL; Zhang QH; Zhen JH; Fang AJ; Lin XY
    Cancer Lett; 2007 Oct; 256(1):81-9. PubMed ID: 17637500
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Overcoming multi-drug resistance using anti-MDR1 ribozymes].
    Wang H; Chen XP; Qiu FZ
    Zhonghua Wai Ke Za Zhi; 2004 Apr; 42(7):424-7. PubMed ID: 15144672
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The reversion of multidrug resistance in tumour cell line MCF-7/Adr by ribozyme].
    Yuan Y; Zhang J; Zhou D
    Zhonghua Yi Xue Za Zhi; 1997 Jul; 77(7):494-6. PubMed ID: 9772447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reversion of multidrug resistance in the P-glycoprotein positive breast cancer cell line (MCF-7/ADR) by introduction of hammerhead ribozyme.
    Yuan Y; Zhang J; Scanlon KJ; Lu Z; Qi G
    Chin Med Sci J; 1998 Mar; 13(1):24-8. PubMed ID: 11717919
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reversal of multidrug resistance by a liposome-MDR1 ribozyme complex.
    Masuda Y; Kobayashi H; Holland JF; Ohnuma T
    Cancer Chemother Pharmacol; 1998; 42(1):9-16. PubMed ID: 9619752
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effects of schisandrin B on reversing multidrug resistance in human breast cancer cells transfected with mdr1 gene].
    Li L; Wang T; Xu ZL; Yu Y; Chen W; Chen F
    Zhonghua Yi Xue Za Zhi; 2005 Jun; 85(23):1633-7. PubMed ID: 16185533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Mdr-1 ribozyme in the reversal of multidrug resistance in human ovarian cancer].
    Yang XK; Xing H; Gao QL; Wang W; Wu SF; Lu YP; Wang SX; Ma D
    Zhonghua Zhong Liu Za Zhi; 2003 Sep; 25(5):425-8. PubMed ID: 14575561
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of multidrug resistance in MOLT-4 cells by anticancer agents is closely related to increased expression of functional P-glycoprotein and MDR1 mRNA.
    Liu ZL; Onda K; Tanaka S; Toma T; Hirano T; Oka K
    Cancer Chemother Pharmacol; 2002 May; 49(5):391-7. PubMed ID: 11976833
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reversal of MDR1 gene-dependent multidrug resistance using short hairpin RNA expression vectors.
    Gan HZ; Zhang GZ; Zhao JS; Zhang FC; Bu LS; Yang SJ; Piao SL; Du ZW; Gao S; Zheng DM
    Chin Med J (Engl); 2005 Jun; 118(11):893-902. PubMed ID: 15978189
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Reversal of mdrl gene-dependent multidrug resistance in multidrug resistance human leukemia cell line K562/ADM using short hairpin RNA expression vectors].
    Gan HZ; Zhang GZ; Lu ZX; Pu LS; Yang SJ; Gao S; Zheng DM
    Zhonghua Xue Ye Xue Za Zhi; 2007 Jun; 28(6):383-7. PubMed ID: 17939403
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selection of antisense oligonucleotides for reversal of multidrug resistance in breast carcinoma cells.
    Gao P; Zhou GY; Lei DP; Zhang XF; Li L; Xu JW; Lin XY
    Cytotherapy; 2007; 9(8):795-801. PubMed ID: 17917879
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reversal effect of isotetrandrine, an isoquinoline alkaloid extracted from Caulis Mahoniae, on P-glycoprotein-mediated doxorubicin-resistance in human breast cancer (MCF-7/DOX) cells.
    Wang TX; Yang XH
    Yao Xue Xue Bao; 2008 May; 43(5):461-6. PubMed ID: 18717331
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overcoming the classical multidrug resistance phenotype by adenoviral delivery of anti-MDR1 short hairpin RNAs and ribozymes.
    Kaszubiak A; Holm PS; Lage H
    Int J Oncol; 2007 Aug; 31(2):419-30. PubMed ID: 17611700
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Small interfering RNA-induced suppression of MDR1 (P-glycoprotein) restores sensitivity to multidrug-resistant cancer cells.
    Wu H; Hait WN; Yang JM
    Cancer Res; 2003 Apr; 63(7):1515-9. PubMed ID: 12670898
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Experimental study of adenovirus-mediated p53 gene on the reversal of multidrug resistance in breast cancer].
    He SZ; Qi XD; Zhang XM; Wang Y
    Zhonghua Yi Xue Za Zhi; 2007 Nov; 87(41):2935-7. PubMed ID: 18261311
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.